Cartesian Therapeutics Inc
NASDAQ:RNAC 4:00:00 PM EDT
| Market Cap (Intraday) | 255.14M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $10.04 |
| 50-Day MA | $10.56 |
| 200-Day MA | $16.28 |
Cartesian Therapeutics Inc Stock, NASDAQ:RNAC
704 Quince Orchard Road, Gaithersburg, Maryland 20878
United States of America
Phone: +1.617.923.1400
Number of Employees: 38
Description
Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company is headquartered in Gaithersburg, MD.